The American Society of Oncology (ASCO) 2020 Annual Meeting was held virtually this year due to the ongoing COVID-19 pandemic. Although the meeting was virtual, the programme was full of the latest data, ongoing controversies in the field and updates on potential new treatments for cancer.

Hot topics at this year’s meeting included immunotherapy, COVID-19 and cancer, developmental therapeutics and care delivery. Data were presented from the latest clinical trials including ADAURA, JAVELIN , E2108 and KEYNOTE-177.

View all videos

ASCO 2020

29–31 May 2020 | Virtual Meeting

🎥 @HamounRozati of @imperialcollege talks on assessing stereotactic radiotherapy in patients with high numbers of brain metastases

Watch: 👉http://ow.ly/ZVlE50JO0rN👈

#BNOS2022 @BNOSofficial #BTSM #RadOnc

🎥 John Strickler of @DukeCancer talks on MOUNTAINEER: Tucatinib plus trastuzumab for HER2+ metastatic colorectal cancer

Watch: 👉http://ow.ly/FB9A50JO0ps👈

@myESMO @ESMOWorldGI #WCGIC22 #CRCsm #ColorectalCancer

longer follow up (3 years) continues to show ctDNA is strongly associated with relapse (HR=6) and a 40% ⬇️ risk of death with atezo in adjuvant UC. There’s a strong rationale for circulating rather than tissue biomarkers here. Imvigor011 (randomised III) tests this prospectively

4

Last day at #EAU22, Outstanding plenary session and inspiring presentations on liquid biomarkers in #RCC
@AStenzl @grantissimus @TurajlicLab @ZeynepZengin @srossi725
@EAUYAU_RenalCa @Uroweb @AmerUrological @KidneyCancer

4

💥 It’s the final day of #EAU22! 💥

The last day is packed with more fantastic speakers, so don’t miss out! Head to http://VJOncology.com for all updates on EAU 2022 so far!

@Uroweb #PCSM #Blcsm #kcsm #uroonc

Load More

ASCO 2020

29–31 May 2020 | Virtual Meeting

The American Society of Oncology (ASCO) 2020 Annual Meeting was held virtually this year due to the ongoing COVID-19 pandemic. Although the meeting was virtual, the programme was full of the latest data, ongoing controversies in the field and updates on potential new treatments for cancer.

Hot topics at this year’s meeting included immunotherapy, COVID-19 and cancer, developmental therapeutics and care delivery. Data were presented from the latest clinical trials including ADAURA, JAVELIN , E2108 and KEYNOTE-177.

View all videos

🎥 @HamounRozati of @imperialcollege talks on assessing stereotactic radiotherapy in patients with high numbers of brain metastases

Watch: 👉http://ow.ly/ZVlE50JO0rN👈

#BNOS2022 @BNOSofficial #BTSM #RadOnc

🎥 John Strickler of @DukeCancer talks on MOUNTAINEER: Tucatinib plus trastuzumab for HER2+ metastatic colorectal cancer

Watch: 👉http://ow.ly/FB9A50JO0ps👈

@myESMO @ESMOWorldGI #WCGIC22 #CRCsm #ColorectalCancer

longer follow up (3 years) continues to show ctDNA is strongly associated with relapse (HR=6) and a 40% ⬇️ risk of death with atezo in adjuvant UC. There’s a strong rationale for circulating rather than tissue biomarkers here. Imvigor011 (randomised III) tests this prospectively

4

Last day at #EAU22, Outstanding plenary session and inspiring presentations on liquid biomarkers in #RCC
@AStenzl @grantissimus @TurajlicLab @ZeynepZengin @srossi725
@EAUYAU_RenalCa @Uroweb @AmerUrological @KidneyCancer

4

💥 It’s the final day of #EAU22! 💥

The last day is packed with more fantastic speakers, so don’t miss out! Head to http://VJOncology.com for all updates on EAU 2022 so far!

@Uroweb #PCSM #Blcsm #kcsm #uroonc

Load More

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter